New Key Statistics Module, Z-Score and F-Score
NAS:EVOK Key Ratios
| Market Cap $ M | 7.28 |
| Enterprise Value $ M | 0.94 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 10.21 |
| Price/Book | 1.00 |
| Price/Sales | 0.41 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 8.00 |
| EPS (TTM) $ | -11.03 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 21.90 |
| 5-y EBITDA Growth Rate % | 18.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.18 |
| EV-to-EBITDA | -0.18 |
| PEG | -- |
| Shares Outstanding M | 1.49 |
| Net Margin (%) | -71.33 |
| Operating Margin % | -68.47 |
| Pre-tax Margin (%) | -71.33 |
| Quick Ratio | 1.39 |
| Current Ratio | 1.44 |
| ROA % (ttm) | -57.26 |
| ROE % (ttm) | -433.12 |
| ROIC % (ttm) | -123.82 |
| Dividend Yield % | -- |
| Altman Z-Score | -12.52 |
EVOK Number of Guru Trades
EVOK Volume of Guru Trades
Gurus Latest Trades with NAS:EVOK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:EVOK is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Evoke Pharma Inc Insider Transactions
No Available Data
News about NAS:EVOK
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers